У нас вы можете посмотреть бесплатно Preventing Infections in Glomerulonephritis - Dr. Martin Windpessl, Prof. Dr. Andreas Kronbichler или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
After a welcome address by Prof. Dr. Anders (Munich, Germany), Editor-in-Chief of NDT - Nephrology Dialysis Transplantation, who introduces the novel cooperation between NDT - Nephrology Dialysis Transplantation and MARKUS at HOMe, Dr. Martin Windpessl (Wels, Austria) and Ass. Prof. PD. Andreas Kronbichler (Innsbruck, Austria) discuss how best to prevent infectious diseases in patients with glomerulonephritis who receive immunosuppressive treatment. Dr. Andreas Kronbichler is Nephrologist and Assistant Professor at the Medical University of Innsbruck, Austria. Dr. Martin Windpessl is Nephrologist in Wels, Austria. Dr. Windpessl and Prof. Dr. Andreas Kronbichler are lead authors of the review paper "Preventing infections in immunocompromised patients with kidney diseases: vaccines and antimicrobial prophylaxis.", which has been published in NDT - Nephrology, Dialysis, Transplantation. The interview was recorded on September 13th, 2023. Moderators: Prof. Dr. Hans-Joachim Anders (Munich, Germany), Dr. Hannah Kaminski (Bordeaux, France) and Prof. Dr. Gunnar Heine (Frankfurt, Germany). Articles discussed: Preventing infections in immunocompromised patients with kidney diseases: vaccines and antimicrobial prophylaxis. Windpessl M, Kostopoulou M, Conway R, Mentese IB, Bruchfeld A, Soler MJ, Sester M, Kronbichler A. Nephrol Dial Transplant. 2023 doi: 10.1093/ndt/gfad080 Welcome editorial by the new NDT Editor-in-Chief Anders HJ Nephrol Dial Transplant. 2023 https://doi.org/10.1093/ndt/gfad055 Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial. Lv J, Zhang H, Wong MG, Jardine MJ, Hladunewich M, Jha V, Monaghan H, Zhao M, Barbour S, Reich H, Cattran D, Glassock R, Levin A, Wheeler D, Woodward M, Billot L, Chan TM, Liu ZH, Johnson DW, Cass A, Feehally J, Floege J, Remuzzi G, Wu Y, Agarwal R, Wang HY, Perkovic V; TESTING Study Group. JAMA. 2017 doi: 10.1001/jama.2017.9362 Herpes zoster in immunocompromised patients: incidence, timing, and risk factors. Wung PK, Holbrook JT, Hoffman GS, Tibbs AK, Specks U, Min YI, Merkel PA, Spiera R, Davis JC, St Clair EW, McCune J, Ytterberg SR, Allen NB, Stone JH; WGET Research Group. Am J Med. 2005 doi: 10.1016/j.amjmed.2005.06.012 Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial. Heerspink HJL, Sjöström CD, Jongs N, Chertow GM, Kosiborod M, Hou FF, McMurray JJV, Rossing P, Correa-Rotter R, Kurlyandskaya R, Stefansson BV, Toto RD, Langkilde AM, Wheeler DC; DAPA-CKD Trial Committees and Investigators. Eur Heart J. 2021 doi: 10.1093/eurheartj/ehab094 Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial. Lv J, Wong MG, Hladunewich MA, Jha V, Hooi LS, Monaghan H, Zhao M, Barbour S, Jardine MJ, Reich HN, Cattran D, Glassock R, Levin A, Wheeler DC, Woodward M, Billot L, Stepien S, Rogers K, Chan TM, Liu ZH, Johnson DW, Cass A, Feehally J, Floege J, Remuzzi G, Wu Y, Agarwal R, Zhang H, Perkovic V; TESTING Study Group. JAMA. 2022 doi: 10.1001/jama.2022.5368 Risk factors for serious infections in ANCA-associated vasculitis. Odler B, ..., Kronbichler A; RAVE−ITN Research Group. Ann Rheum Dis. 2023 doi: 10.1136/ard-2022-223401 Trimethoprim-sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis. Kronbichler A, ..., Jayne DRW. Ann Rheum Dis. 2018 doi: 10.1136/annrheumdis-2017-212861 Sodium-glucose cotransporter 2 inhibition in primary and secondary glomerulonephritis. Caravaca-Fontán F, Stevens K, Padrón M, Huerta A, Montomoli M, Villa J, González F, Vega C, López Mendoza M, Fernández L, Shabaka A, Rodríguez-Moreno A, Martín-Gómez A, Labrador PJ, Molina Andújar A, Soler MCP, Martín-Penagos L, Yerovi E, Medina Zahonero L, De La Flor JC, Mon C, Ibernon M, Gómez AR, Miquel R, Sierra M, Mascarós V, Luzardo L, Papasotiriou M, Arroyo D, Verdalles Ú, Martínez-Miguel P, Ramírez-Guerrero G, Pampa-Saico S, Moral Berrio E, Canga JLP, Tarragón B, Gómez PF, Regidor D, Relea J, Xipell M, Gómez CA, Navarro M, Álvarez Á, Rivas B, Quintana LF, Gutiérrez E, Pérez-Valdivia MÁ, Odler B, Kronbichler A, Geddes C, Anders HJ, Floege J, Fernández-Juárez G, Praga M; Spanish Group for the Study of Glomerular Diseases (GLOSEN) and the Immunonephrology Working Group of the European Renal Association (ERA). Nephrol Dial Transplant. 2023 doi: 10.1093/ndt/gfad175 Hepatitis B reactivation in patients with multiple myeloma treated with anti-CD38 monoclonal antibody-based therapies: a pharmacovigilance analysis. Moore DC, Elmes JB, Arnall JR, Strassels SA, Patel JN. Int J Clin Pharm. 2023 doi: 10.1007/s11096-023-01608-7